You can keep posting this set of so-called "facts" every week if you want, but I will be looking for your postings so that I can call them out for the lies and speculation that they are. This Nanalyze article is twisting the fact that this a dynamic biotech startup with many potential blockbuster drugs into stock that will "absolutely fail" because none of these have gone to market and produced revenue yet. 90% of these subpennies have no significant revenue, but only one in a million have the potential that this has. But I don't think I have to tell you that... I am sure you will be buying along with everyone else if you succeed in bashing it down to your preferred buy point.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.